RFG
GMAB icon

RFP Financial Group’s Genmab GMAB Stock Holding History

RFP Financial Group’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-156
Closed -$3.92K – 384
2024
Q2 		$3.92K Hold
156
– – ﹤0.01% 612
2024
Q1 		$4.67K Sell
156
-65
-29% -$1.91K ﹤0.01% 543
2023
Q4 		$7.04K Buy
221
+156
+240% +$4.9K ﹤0.01% 470
2023
Q3 		$2.29K Hold
65
– – ﹤0.01% 637
2023
Q2 		$2.47K Hold
65
– – ﹤0.01% 663
2023
Q1 		$2.45K Hold
65
– – ﹤0.01% 484
2022
Q4 		$2.75K Buy
+65
New +$2.68K ﹤0.01% 598

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

RFP Financial Group's GMAB Position: Q3 2024 in Review

RFP Financial Group sold out of Genmab (GMAB) in Q3 2024, closing a stake of 156 shares — an estimated $3.92K sold.

RFP Financial Group first reported a position in GMAB in Q4 2022 and held it in 7 quarters. The position peaked at $7.04K in Q4 2023. 223 funds tracked by Wall St. Rank hold GMAB as of Q3 2024.

  • RFP Financial Group reported no remaining Genmab position as of Q3 2024 after selling out during the quarter.
  • RFP Financial Group sold 156 Genmab shares in Q3 2024, an estimated $3.92K.
  • RFP Financial Group first reported a position in Genmab in Q4 2022 and held it in 7 quarters.
  • RFP Financial Group's Genmab position peaked at $7.04K in Q4 2023.
  • 223 funds tracked by Wall St. Rank held Genmab as of Q3 2024.

Based on RFP Financial Group's 13F filing for Q3 2024, filed 21 Oct 2024.